These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25176166)

  • 1. Reverse translation of clinical electrophysiological biomarkers in behaving rodents under acute and chronic NMDA receptor antagonism.
    Sullivan EM; Timi P; Hong LE; O'Donnell P
    Neuropsychopharmacology; 2015 Feb; 40(3):719-27. PubMed ID: 25176166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test-retest reliability of tone- and 40 Hz train-evoked gamma oscillations in female rats and their sensitivity to low-dose NMDA channel blockade.
    Raza MU; Sivarao DV
    Psychopharmacology (Berl); 2021 Aug; 238(8):2325-2334. PubMed ID: 33944972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine can produce oscillatory dynamics by engaging mechanisms dependent on the kinetics of NMDA receptors.
    Adam E; Kowalski M; Akeju O; Miller EK; Brown EN; McCarthy MM; Kopell N
    Proc Natl Acad Sci U S A; 2024 May; 121(22):e2402732121. PubMed ID: 38768339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Quantitative Electroencephalography to Inform Age- and Sex-Related Differences in NMDA Receptor Function Following MK-801 Administration.
    Holter KM; Lekander AD; Pierce BE; Sands LP; Gould RW
    Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine can produce oscillatory dynamics by engaging mechanisms dependent on the kinetics of NMDA receptors.
    Adam E; Kowalski M; Akeju O; Miller EK; Brown EN; McCarthy MM; Kopell N
    bioRxiv; 2024 Apr; ():. PubMed ID: 38617266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology.
    Javitt DC; Siegel SJ; Spencer KM; Mathalon DH; Hong LE; Martinez A; Ehlers CL; Abbas AI; Teichert T; Lakatos P; Womelsdorf T
    Neuropsychopharmacology; 2020 Aug; 45(9):1411-1422. PubMed ID: 32375159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of NMDA and GABA-A Receptor Antagonism on Auditory Steady-State Synchronization in Awake Behaving Rats.
    Sullivan EM; Timi P; Hong LE; O'Donnell P
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu118. PubMed ID: 25556198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of glutamatergic and GABAergic transmission in MK-801-increased gamma band oscillation power in rat cortical electroencephalograms.
    Hiyoshi T; Kambe D; Karasawa J; Chaki S
    Neuroscience; 2014 Nov; 280():262-74. PubMed ID: 25220900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BICC1 expression is elevated in depressed subjects and contributes to depressive behavior in rodents.
    Ota KT; Andres W; Lewis DA; Stockmeier CA; Duman RS
    Neuropsychopharmacology; 2015 Feb; 40(3):711-8. PubMed ID: 25178406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical EEG oscillations and network connectivity as efficacy indices for assessing drugs with cognition enhancing potential.
    Ahnaou A; Huysmans H; Jacobs T; Drinkenburg WH
    Neuropharmacology; 2014 Nov; 86():362-77. PubMed ID: 25181033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and pharmacokinetic properties of JNJ-40411813, a positive allosteric modulator of the mGlu2 receptor.
    Lavreysen H; Ahnaou A; Drinkenburg W; Langlois X; Mackie C; Pype S; Lütjens R; Le Poul E; Trabanco AA; Nuñez JM
    Pharmacol Res Perspect; 2015 Feb; 3(1):e00096. PubMed ID: 25692015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of cyclin-dependent kinase 5 from parvalbumin interneurons leads to hyperinhibition, decreased anxiety, and memory impairment.
    Rudenko A; Seo J; Hu J; Su SC; de Anda FC; Durak O; Ericsson M; Carlén M; Tsai LH
    J Neurosci; 2015 Feb; 35(6):2372-83. PubMed ID: 25673832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural oscillations as a translational tool in schizophrenia research: rationale, paradigms and challenges.
    Phillips KG; Uhlhaas PJ
    J Psychopharmacol; 2015 Feb; 29(2):155-68. PubMed ID: 25567552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice with subtle reduction of NMDA NR1 receptor subunit expression have a selective decrease in mismatch negativity: Implications for schizophrenia prodromal population.
    Featherstone RE; Shin R; Kogan JH; Liang Y; Matsumoto M; Siegel SJ
    Neurobiol Dis; 2015 Jan; 73():289-95. PubMed ID: 25461194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative versus positive allosteric modulation of metabotropic glutamate receptors (mGluR5): indices for potential pro-cognitive drug properties based on EEG network oscillations and sleep-wake organization in rats.
    Ahnaou A; Langlois X; Steckler T; Bartolome-Nebreda JM; Drinkenburg WH
    Psychopharmacology (Berl); 2015 Mar; 232(6):1107-22. PubMed ID: 25323624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Inflammation and Normocytic Anemia in DOCK11 Deficiency.
    Block J; Rashkova C; Castanon I; Zoghi S; Platon J; Ardy RC; Fujiwara M; Chaves B; Schoppmeyer R; van der Made CI; Jimenez Heredia R; Harms FL; Alavi S; Alsina L; Sanchez Moreno P; Ávila Polo R; Cabrera-Pérez R; Kostel Bal S; Pfajfer L; Ransmayr B; Mautner AK; Kondo R; Tinnacher A; Caldera M; Schuster M; Domínguez Conde C; Platzer R; Salzer E; Boyer T; Brunner HG; Nooitgedagt-Frons JE; Iglesias E; Deyà-Martinez A; Camacho-Lovillo M; Menche J; Bock C; Huppa JB; Pickl WF; Distel M; Yoder JA; Traver D; Engelhardt KR; Linden T; Kager L; Hannich JT; Hoischen A; Hambleton S; Illsinger S; Da Costa L; Kutsche K; Chavoshzadeh Z; van Buul JD; Antón J; Calzada-Hernández J; Neth O; Viaud J; Nishikimi A; Dupré L; Boztug K
    N Engl J Med; 2023 Aug; 389(6):527-539. PubMed ID: 37342957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the study of phencyclidine-induced schizophrenia-like animal models and the underlying neural mechanisms.
    Li D; Pan Q; Xiao Y; Hu K
    Schizophrenia (Heidelb); 2024 Jul; 10(1):65. PubMed ID: 39039065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine plus Alcohol: What We Know and What We Can Expect about This.
    Kobayashi NHC; Farias SV; Luz DA; Machado-Ferraro KM; Conceição BCD; Silveira CCMD; Fernandes LMP; Cartágenes SC; Ferreira VMM; Fontes-Júnior EA; Maia CDSF
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep-Wake Rhythm and Oscillatory Pattern Analysis in a Multiple Hit Schizophrenia Rat Model (Wisket).
    Adlan LG; Csordás-Nagy M; Bodosi B; Kalmár G; Nyúl LG; Nagy A; Kekesi G; Büki A; Horvath G
    Front Behav Neurosci; 2021; 15():799271. PubMed ID: 35153694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial.
    Lijffijt M; Murphy N; Iqbal S; Green CE; Iqbal T; Chang LC; Haile CN; Hirsch LC; Ramakrishnan N; Fall DA; Swann AC; Al Jurdi RK; Mathew SJ
    Neuropsychopharmacology; 2022 Apr; 47(5):1088-1095. PubMed ID: 34839364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.